Bellerophon Therapeutics Historical PE Ratio image   This BLPH PE ratio history page last updated 11/15/2022
Bellerophon Therapeutics Historical PE Ratio Chart
PeriodPriceGAAPAnnualizedPE
Q3 2022
11/14/2022
1.12-0.53-2.12NA
Q2 2022
8/15/2022
1.40-0.43-1.72NA
Q1 2022
5/11/2022
0.85-0.59-2.36NA
Q4 2021
3/31/2022
2.36-0.45-1.80NA
Q3 2021
11/15/2021
3.39-0.49-1.96NA
Q2 2021
8/5/2021
4.16-0.36-1.44NA
Q1 2021
5/11/2021
4.00-0.58-2.32NA
Q4 2020
3/11/2021
6.70-0.84-3.36NA
Q3 2020
11/5/2020
9.17-0.84-3.36NA
Q2 2020
8/5/2020
12.56-0.51-2.04NA
Q1 2020
5/11/2020
20.28-1.08-4.32NA
Q4 2019
4/6/2020
10.24-0.89-3.56NA
Q3 2019
11/6/2019
6.86-0.90-3.60NA
Q2 2019
8/8/2019
9.75-0.90-3.60NA
Q1 2019
5/9/2019
10.05-0.15-0.60NA
Q4 2018
3/14/2019
10.28-1.20-4.80NA
Q3 2018
11/7/2018
14.55-1.50-6.00NA
Q2 2018
8/1/2018
37.95-3.00-12.00NA
Q1 2018
5/10/2018
32.55-0.60-2.40NA
Q4 2017
3/15/2018
28.50-6.60-26.40NA
Q3 2017
11/7/2017
20.40-3.30-13.20NA
Q2 2017
8/7/2017
17.85-1.80-7.20NA
Q1 2017
5/15/2017
22.35-9.00-36.00NA
Q4 2016
3/13/2017
25.05-5.55-22.20NA
Q3 2016
11/8/2016
14.25-4.50-18.00NA
Q2 2016
8/9/2016
23.55-5.85-23.40NA
Q1 2016
5/10/2016
21.00-8.10-32.40NA
Q4 2015
3/21/2016
43.35-12.30-49.20NA
Q3 2015
11/12/2015
45.45-12.90-51.60NA
Q2 2015
8/13/2015
50.25-13.50-54.00NA
Q1 2015
5/15/2015
129.90-19.05-76.20NA
Q4 2014
3/31/2015
137.70-27.60-110.40NA
Bellerophon Therapeutics PE History Chart
PeriodPriceGAAPTTMPE
Q3 2022
11/14/2022
1.12-0.53-2.00NA
Q2 2022
8/15/2022
1.40-0.43-1.96NA
Q1 2022
5/11/2022
0.85-0.59-1.89NA
Q4 2021
3/31/2022
2.36-0.45-1.88NA
Q3 2021
11/15/2021
3.39-0.49-2.27NA
Q2 2021
8/5/2021
4.16-0.36-2.62NA
Q1 2021
5/11/2021
4.00-0.58-2.77NA
Q4 2020
3/11/2021
6.70-0.84-3.27NA
Q3 2020
11/5/2020
9.17-0.84-3.32NA
Q2 2020
8/5/2020
12.56-0.51-3.38NA
Q1 2020
5/11/2020
20.28-1.08-3.77NA
Q4 2019
4/6/2020
10.24-0.89-2.84NA
Q3 2019
11/6/2019
6.86-0.90-3.15NA
Q2 2019
8/8/2019
9.75-0.90-3.75NA
Q1 2019
5/9/2019
10.05-0.15-5.85NA
Q4 2018
3/14/2019
10.28-1.20-6.30NA
Q3 2018
11/7/2018
14.55-1.50-11.70NA
Q2 2018
8/1/2018
37.95-3.00-13.50NA
Q1 2018
5/10/2018
32.55-0.60-12.30NA
Q4 2017
3/15/2018
28.50-6.60-20.70NA
Q3 2017
11/7/2017
20.40-3.30-19.65NA
Q2 2017
8/7/2017
17.85-1.80-20.85NA
Q1 2017
5/15/2017
22.35-9.00-24.90NA
Q4 2016
3/13/2017
25.05-5.55-24.00NA
Q3 2016
11/8/2016
14.25-4.50-30.75NA
Q2 2016
8/9/2016
23.55-5.85-39.15NA
Q1 2016
5/10/2016
21.00-8.10-46.80NA
Q4 2015
3/21/2016
43.35-12.30-57.75NA
Q3 2015
11/12/2015
45.45-12.90-73.05NA
Q2 2015
8/13/2015
50.25-13.50NANA
Q1 2015
5/15/2015
129.90-19.05NANA
Q4 2014
3/31/2015
137.70-27.60NANA
Quotes delayed 20 minutes

Email EnvelopeFree BLPH Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks
10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
Bellerophon Therapeutics (BLPH) is categorized under the Healthcare sector; to help you further research PE history across stocks, below are some other companies in the same sector:

BLUE PE Ratio History
BMEA PE Ratio History
BMRA PE Ratio History
BMRN PE Ratio History
BMY PE Ratio History
BNGO PE Ratio History
BOLT PE Ratio History
BPMC PE Ratio History
BPTH PE Ratio History
BRKR PE Ratio History
How should the BLPH historical PE ratio be determined?
Realizing that PE stands for Price to Earnings ratio, we need two values to compute it: stock price and earnings per share. The stock price at any given date is a known historical value, but what about the earnings number to use?

✔️Accepted answer: There are a number of different approaches when it comes to calculating a historical PE ratio for a company like Bellerophon Therapeutics. We like to take our measurements on each of the past quarterly earnings reports. That only leaves the question of whether the earnings number at that quarterly report should be used on an annualized basis, or some other method. We approach this question using three different methods, on this BLPH Historical PE Ratio page.

What is the average historical PE for BLPH based on annualized quarterly earnings?
As we look back through earnings history, what is the resulting PE calculation if at each measurement period we use that quarter's earnings result annualized?

✔️Accepted answer: The BLPH historical PE ratio using the annualized quarterly earnings method works out to NA.

What is the average historical PE for BLPH based on trailing twelve month earnings?
As we look back through earnings history, what is the resulting PE calculation if at each measurement period we use the trailing twelve months combined earnings result in the calculation?

✔️Accepted answer: The BLPH historical PE ratio using the TTM earnings method works out to NA.

On this page we presented the Bellerophon Therapeutics Historical PE Ratio information for Bellerophon Therapeutics' stock. The average BLPH historical PE based on using the annualized quarterly earnings result at each measurement period (for the "E" in the PE calculation; and the closing price on earnings date as the "P") is NA. Meanwhile, using the trailing twelve month (TTM) quarterly earnings result as our method of calculation the "E" value at each measurement period, the average BLPH historical PE based on this TTM earnings result method is NA. Note: any PE calculations involving negative earnings were discarded as not meaningful.

Let's now compare this BLPH historical PE result, against the recent PE: when this page was posted on 11/14/2022, the most recent closing price for BLPH had been 1.12, and the most recent quarterly earnings result, annualized, was NA. Meanwhile, the most recent TTM earnings summed to NA.

For self directed investors doing their due diligence on BLPH or any other given stock, valuation analysis for BLPH can greatly benefit from studying the past earnings and resulting PE calculations. This exercise can help inform an analysis as to whether the past earnings trajectory and current versus historical PE ratios justify the current stock value.

That's why we bring you HistoricalPERatio.com to make it easy for investors to investigate Bellerophon Therapeutics PE history or the past PE information for any stock in our coverage universe. And in your continued research we hope you will be sure to check out the further links included for earnings surprises history (beat/miss data) as well as next earnings dates for BLPH. Thanks for visiting, and the next time you need to research BLPH Historical PE Ratio or the ratio for another stock, we hope you'll think of our site, as your go-to historical PE ratio research resource of choice.

Recommended: OUNZ Average Annual Return, Institutional Holders of CSBK, LGLV Options Chain.

 

Bellerophon Therapeutics Historical PE Ratio | www.HistoricalPERatio.com | Copyright © 2020 - 2022, All Rights Reserved

Nothing in HistoricalPERatio.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.